SUN PHARMACEUTICAL INDUSTRIES

A history of pharmaceutical excellence and innovation

Sun Pharmaceutical Industries Ltd is the fourth largest specialty-generic pharmaceutical company in the world. We provide high-quality, affordable medicines which are trusted by healthcare professionals and patients in more than 150 countries globally.

Driven by Innovation

SUN PHARMA invests six-seven percent of global revenues into research & development. R&D initiatives are led by a strong team of around 2,000 scientists based at our R&D facilities around the world.

South Africa

Sun Pharma is ranked among the top seven generic pharmaceutical companies in South Africa, and provides prescription medicines to treat disorders and diseases of the gastro intestinal tract, cardiovascular system, central nervous system as well as anti-infectives, pain products, oncology therapies, ARVs – and a range of over-the-counter products.

SUN PHARMA acquired Ranbaxy in 2014 and today SUN PHARMA South Africa employs 500 people and is made up of four entities: SUN PHARMA (PTY) Ltd, Ranbaxy SA (Pty) Ltd, Ranbaxy Pharmaceuticals (Pty) Ltd and Sonke Pharmaceuticals (Pty) Ltd – the largest supplier of ARV medicines to the

South African Government, and an essential partner in controlling the AIDS epidemic.

We remain committed to providing affordable pharmaceutical products of global quality standards to patients all over the world. T +27 (0)12 643 2000 E shailesh.somvanshi@sunpharma.com www.sunpharma.com